All In Biotech

Drug Trial Radar · NCT07654283

Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B in the North America and Europe Regions

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Sep 1, 2026

Primary completion

Nov 11, 2027

Study completion Mar 30, 2029

Sponsor

Lead sponsor
AusperBio Therapeutics Inc.Industry
Sponsor type
Industry
First posted
Jun 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with CHB treated with Nucleos(t)ide Analogue (NAs).

Conditions

  • Hepatitis B, Chronic

Interventions

  • AHB-137Drug

    Subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with persistent HBsAg < limit of detection (LOD) and HBV DNA < lower limit of quantification (LLOQ)Time frame: 24 Weeks post AHB-137 treatment (Week 48)

Locations

10 sites in 6 countries. Site status is shown where the registry gives one.

  • Stanford University School of Medicine

    Redwood City, California · Not yet recruiting

  • Institute of Human Virology

    Baltimore, Maryland · Not yet recruiting

  • NYU Langone Health

    New York, New York · Not yet recruiting

  • Texas Liver Institute

    San Antonio, Texas · Recruiting

  • University of Calgary

    Calgary, Alberta, Canada · Not yet recruiting

  • Toronto General Hospital

    Toronto, Ontario, Canada · Not yet recruiting

  • APHP Hôpital Beaujon

    Clichy, France · Not yet recruiting

  • Clinica Mangiagalli

    Milan, Milan, Italy · Not yet recruiting

  • Vall d'Hebron Hospital

    Barcelona, Barcelona, Spain · Not yet recruiting

  • King's College Hospital

    London, London, United Kingdom · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.